Jiangsu GDK Biotechnology Co Ltd (688670) - Total Liabilities

Latest as of June 2025: CN¥238.19 Million CNY ≈ $34.85 Million USD

Based on the latest financial reports, Jiangsu GDK Biotechnology Co Ltd (688670) has total liabilities worth CN¥238.19 Million CNY (≈ $34.85 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Jiangsu GDK Biotechnology Co Ltd (688670) cash flow conversion to assess how effectively this company generates cash.

Jiangsu GDK Biotechnology Co Ltd - Total Liabilities Trend (2017–2024)

This chart illustrates how Jiangsu GDK Biotechnology Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Jiangsu GDK Biotechnology Co Ltd (688670) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Jiangsu GDK Biotechnology Co Ltd Competitors by Total Liabilities

The table below lists competitors of Jiangsu GDK Biotechnology Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Ouro Fino Saúde Animal Participações S.A SA:OFSA3	Brazil	R$768.97 Million
Biglari Holdings Inc NYSE:BH-A	USA	$525.71 Million
ALPHA KLSE:0303	Malaysia	RM58.34 Million
Lanzhou Zhuangyuan Pasture Co Ltd SHE:002910	China	CN¥1.28 Billion
Air Asia Co Ltd TW:2630	Taiwan	NT$2.77 Billion
Premier Explosives Limited NSE:PREMEXPLN	India	Rs2.22 Billion
Telos Corp NASDAQ:TLS	USA	$43.91 Million
Firm Capital Mortgage Invest Corp TO:FC	Canada	CA$172.31 Million

Liability Composition Analysis (2017–2024)

This chart breaks down Jiangsu GDK Biotechnology Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Jiangsu GDK Biotechnology Co Ltd market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.43	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.19	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.16	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Jiangsu GDK Biotechnology Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Jiangsu GDK Biotechnology Co Ltd (2017–2024)

The table below shows the annual total liabilities of Jiangsu GDK Biotechnology Co Ltd from 2017 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥255.33 Million ≈ $37.36 Million	-1.99%
2023-12-31	CN¥260.52 Million ≈ $38.12 Million	-29.03%
2022-12-31	CN¥367.11 Million ≈ $53.72 Million	+25.24%
2021-12-31	CN¥293.12 Million ≈ $42.89 Million	-45.26%
2020-12-31	CN¥535.47 Million ≈ $78.36 Million	+5.89%
2019-12-31	CN¥505.68 Million ≈ $74.00 Million	+26.19%
2018-12-31	CN¥400.73 Million ≈ $58.64 Million	+11.50%
2017-12-31	CN¥359.39 Million ≈ $52.59 Million	--

About Jiangsu GDK Biotechnology Co Ltd

SHG:688670 China Biotechnology

Market Cap

$323.06 Million

CN¥2.21 Billion CNY

Market Cap Rank

#14655 Global

#4566 in China

Share Price

CN¥17.92

Change (1 day)

+1.07%

52-Week Range

CN¥12.20 - CN¥30.90

All Time High

CN¥75.07